Related Experiment Videos
Correlation between eosinophilia induced by CD4(+) T cells and bronchial hyper-responsiveness
A Nakata1, O Kaminuma, K Ogawa
1Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd, 2-2-50 Kawagishi, Toda, Saitama 335-8505, Japan.
International Immunology
|February 27, 2001
Summary
CD4(+) T cells drive airway eosinophilic inflammation and bronchial hyper-responsiveness (BHR). Interleukin-5 (IL-5) is crucial, as blocking it suppresses these asthma-like responses in mice.
Area of Science:
- Immunology
- Respiratory Medicine
- Allergy Research
Background:
- Airway inflammation and bronchial hyper-responsiveness (BHR) are key features of asthma.
- CD4(+) T cells play a central role in orchestrating inflammatory responses in the airways.
Purpose of the Study:
- To investigate the causal link between CD4(+) T cell-mediated eosinophilic airway inflammation and BHR.
- To elucidate the role of specific cytokines, particularly IL-5, in these processes.
Main Methods:
- Adoptive transfer of ovalbumin-reactive T helper (Th) 0 clones into BALB/c mice.
- Antigen challenge via inhalation to induce airway inflammation and BHR.
- Administration of monoclonal antibodies (mAbs) against IL-5, IL-4, IFN-gamma, and IL-2 to assess cytokine roles.
Main Results:
- Antigen challenge led to airway infiltration by T cells, eosinophil accumulation, goblet cell hyperplasia, and increased BHR.
- The degree of eosinophilia strongly correlated with the IL-5 production capacity of the transferred T cells.
- Anti-IL-5 mAb treatment significantly suppressed both eosinophilic inflammation and BHR.
- Anti-IL-4 and anti-IFN-gamma mAbs exacerbated eosinophilia and BHR, while anti-IL-2 mAb had no effect.
- A significant correlation was observed between accumulated eosinophil numbers and BHR intensity.
Conclusions:
- CD4(+) T cells induce BHR through eosinophilic airway inflammation.
- Interleukin-5 (IL-5) is a critical regulator of both eosinophilic inflammation and BHR in this model.
- Targeting IL-5 may be a viable therapeutic strategy for managing asthma-related airway hyper-responsiveness.